Cargando…

In Vivo protection from SARS-CoV-2 infection by ATN-161 in k18-hACE2 transgenic mice

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an infectious disease that has spread worldwide. Current treatments are limited in both availability and efficacy, such that improving our understanding of the factors that facilitate infection is urgently needed to more effectively tre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Amruta, Narayanappa, Engler-Chiurazzi, Elizabeth B., Murray-Brown, Isabel C., Gressett, Timothy E., Biose, Ifechukwude J., Chastain, Wesley H., Befeler, Jaime B., Bix, Gregory
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352850/ https://www.ncbi.nlm.nih.gov/pubmed/34389403 http://dx.doi.org/10.1016/j.lfs.2021.119881

Ejemplares similares

SARS-CoV-2 mediated neuroinflammation and the impact of COVID-19 in neurological disorders
por: Amruta, Narayanappa, et al.
Publicado: (2021)

ATN-161 Ameliorates Ischemia/Reperfusion-induced Oxidative Stress, Fibro-inflammation, Mitochondrial damage, and Apoptosis-mediated Tight Junction Disruption in bEnd.3 Cells
por: Amruta, Narayanappa, et al.
Publicado: (2021)

The Integrin Binding Peptide, ATN-161, as a Novel Therapy for SARS-CoV-2 Infection
por: Beddingfield, Brandon J., et al.
Publicado: (2020)

Effect of acetic acid inactivation of SARS-CoV-2
por: Amruta, Narayanappa, et al.
Publicado: (2023)

Mouse Adapted SARS-CoV-2 (MA10) Viral Infection Induces Neuroinflammation in Standard Laboratory Mice
por: Amruta, Narayanappa, et al.
Publicado: (2022)

A Mediterranean Diet Enhances Cognitive Function and Modulates the Gut Microbiota
por: Solch, Rebecca, et al.
Publicado: (2022)

Penta-peptide ATN-161 based neutralization mechanism of SARS-CoV-2 spike protein
por: Rabbani, Gulam, et al.
Publicado: (2021)

Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infection
por: Rathnasinghe, Raveen, et al.
Publicado: (2020)

Promising Cerebral Blood Flow Enhancers in Acute Ischemic Stroke
por: Biose, Ifechukwude Joachim, et al.
Publicado: (2022)

Perlecan: a review of its role in neurologic and musculoskeletal disease
por: Lavorgna, Tessa R., et al.
Publicado: (2023)

Review of Alterations in Perlecan-Associated Vascular Risk Factors in Dementia
por: Trout, Amanda L., et al.
Publicado: (2020)

Comparison of Transgenic and Adenovirus hACE2 Mouse Models for SARS-CoV-2 Infection
por: Rathnasinghe, Raveen, et al.
Publicado: (2020)

Effects of simeprevir on the replication of SARS-CoV-2 in vitro and in transgenic hACE2 mice
por: Muturi, Elishiba, et al.
Publicado: (2022)

Pathogenicity of severe acute respiratory coronavirus deletion mutants in hACE-2 transgenic mice
por: DeDiego, Marta L., et al.
Publicado: (2008)

The Tissue Distribution of SARS-CoV-2 in Transgenic Mice With Inducible Ubiquitous Expression of hACE2
por: Dolskiy, Alexander A., et al.
Publicado: (2022)

Chronological brain lesions after SARS-CoV-2 infection in hACE2-transgenic mice
por: Vidal, Enric, et al.
Publicado: (2021)

The Potential Role of Integrin Signaling in Memory and Cognitive Impairment
por: Biose, Ifechukwude Joachim, et al.
Publicado: (2023)

Fatal Neurodissemination and SARS-CoV-2 Tropism in K18-hACE2 Mice Is Only Partially Dependent on hACE2 Expression
por: Carossino, Mariano, et al.
Publicado: (2022)

Highly susceptible SARS-CoV-2 model in CAG promoter–driven hACE2-transgenic mice
por: Asaka, Masamitsu N., et al.
Publicado: (2021)

An inducible hACE2 transgenic mouse model recapitulates SARS-CoV-2 infection and pathogenesis in vivo
por: Liu, Kuo, et al.
Publicado: (2023)

Perlecan, A Multi-Functional, Cell-Instructive, Matrix-Stabilizing Proteoglycan With Roles in Tissue Development Has Relevance to Connective Tissue Repair and Regeneration
por: Hayes, Anthony J., et al.
Publicado: (2022)

Omicron sub-lineage BA.5 infection results in attenuated pathology in hACE2 transgenic mice
por: Rizvi, Zaigham Abbas, et al.
Publicado: (2023)

Phase 1 trial of the antiangiogenic peptide ATN-161 (Ac-PHSCN-NH(2)), a beta integrin antagonist, in patients with solid tumours
por: Cianfrocca, M E, et al.
Publicado: (2006)

Optimizing intraluminal monofilament model of ischemic stroke in middle-aged Sprague–Dawley rats
por: Biose, I. J., et al.
Publicado: (2022)

SARS-CoV-2 infection of hACE2 transgenic mice causes severe lung inflammation and impaired function
por: Winkler, Emma S., et al.
Publicado: (2020)

K18- and CAG-hACE2 Transgenic Mouse Models and SARS-CoV-2: Implications for Neurodegeneration Research
por: Dedoni, Simona, et al.
Publicado: (2022)

Comparative pathology of the nasal epithelium in K18-hACE2 Tg mice, hACE2 Tg mice, and hamsters infected with SARS-CoV-2
por: Yu, Pin, et al.
Publicado: (2022)

Inhibitors of endosomal acidification suppress SARS-CoV-2 replication and relieve viral pneumonia in hACE2 transgenic mice
por: Shang, Chao, et al.
Publicado: (2021)

Effect of severe acute respiratory syndrome coronavirus 2 infection during pregnancy in K18-hACE2 transgenic mice
por: Kim, Byeongseok, et al.
Publicado: (2023)

Therapeutic Effect of C-Vx Substance in K18-hACE2 Transgenic Mice Infected with SARS-CoV-2
por: Ulbegi Polat, Hivda, et al.
Publicado: (2023)

BNT162b2 Vaccine Encoding the SARS-CoV-2 P2 S Protects Transgenic hACE2 Mice against COVID-19
por: Ji, Rui-Ru, et al.
Publicado: (2021)

Recombinant Human Perlecan DV and Its LG3 Subdomain Are Neuroprotective and Acutely Functionally Restorative in Severe Experimental Ischemic Stroke
por: Biose, Ifechukwude Joachim, et al.
Publicado: (2022)

Efficacy of GC-376 against SARS-CoV-2 virus infection in the K18 hACE2 transgenic mouse model
por: Cáceres, C. Joaquín, et al.
Publicado: (2021)

Exploring the disruption of SARS-CoV-2 RBD binding to hACE2
por: Carter, Camryn, et al.
Publicado: (2023)

ATN-161 as an Integrin α5β1 Antagonist Depresses Ocular Neovascularization by Promoting New Vascular Endothelial Cell Apoptosis
por: Sui, Ailing, et al.
Publicado: (2018)

Transchromosomic bovine-derived anti-SARS-CoV-2 polyclonal human antibodies protects hACE2 transgenic hamsters against multiple variants
por: Gilliland, Theron, et al.
Publicado: (2023)

Post-exposure protection of SARS-CoV-2 lethal infected K18-hACE2 transgenic mice by neutralizing human monoclonal antibody
por: Rosenfeld, Ronit, et al.
Publicado: (2021)

Inhibition of Autophagy Suppresses SARS-CoV-2 Replication and Ameliorates Pneumonia in hACE2 Transgenic Mice and Xenografted Human Lung Tissues
por: Shang, Chao, et al.
Publicado: (2021)

The Effects of ATIR Blocker on the Severity of COVID-19 in Hypertensive Inpatients and Virulence of SARS-CoV-2 in Hypertensive hACE2 Transgenic Mice
por: Jiang, Xiaoliang, et al.
Publicado: (2022)

Heterogeneous Infectivity and Pathogenesis of SARS-CoV-2 Variants Beta, Delta and Omicron in Transgenic K18-hACE2 and Wildtype Mice
por: Tarrés-Freixas, Ferran, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_21o5kidfck3vcdeq5m83rnl9a9